FDA’s New Neonatology Panel To Discuss Challenges In Study Design, Conduct
This article was originally published in The Pink Sheet Daily
Executive Summary
Discussion by the Pediatric Advisory Committee’s new subcommittee at a March 15 meeting will aid the agency’s development of a strategic plan for advancing neonatal science; FDA also is looking to outside contractors for help in meeting a FDASIA mandate to bolster neonatology expertise and encourage studies.